229 related articles for article (PubMed ID: 17703068)
1. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle.
Singh M; Cowell L; Seo S; O'Neill G; Golemis E
Cell Biochem Biophys; 2007; 48(1):54-72. PubMed ID: 17703068
[TBL] [Abstract][Full Text] [Related]
2. CAS proteins in normal and pathological cell growth control.
Tikhmyanova N; Little JL; Golemis EA
Cell Mol Life Sci; 2010 Apr; 67(7):1025-48. PubMed ID: 19937461
[TBL] [Abstract][Full Text] [Related]
3. NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma.
Speranza MC; Frattini V; Pisati F; Kapetis D; Porrati P; Eoli M; Pellegatta S; Finocchiaro G
Oncotarget; 2012 Jul; 3(7):723-34. PubMed ID: 22869051
[TBL] [Abstract][Full Text] [Related]
4. NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice.
Gabbasov R; Xiao F; Howe CG; Bickel LE; O'Brien SW; Benrubi D; Do TV; Zhou Y; Nicolas E; Cai KQ; Litwin S; Seo S; Golemis EA; Connolly DC
Oncogene; 2018 Aug; 37(35):4854-4870. PubMed ID: 29773902
[TBL] [Abstract][Full Text] [Related]
5. Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton.
Guerrero MS; Parsons JT; Bouton AH
Genes Cancer; 2012 May; 3(5-6):371-81. PubMed ID: 23226575
[TBL] [Abstract][Full Text] [Related]
6. Exosomal lipids impact on tumoral cell behavior.
Lombardo D; Siret C; Beloribi-Djefaflia S
Cell Cycle; 2015; 14(4):461-2. PubMed ID: 25590870
[No Abstract] [Full Text] [Related]
7. NEDD9 promotes oncogenic signaling in mammary tumor development.
Izumchenko E; Singh MK; Plotnikova OV; Tikhmyanova N; Little JL; Serebriiskii IG; Seo S; Kurokawa M; Egleston BL; Klein-Szanto A; Pugacheva EN; Hardy RR; Wolfson M; Connolly DC; Golemis EA
Cancer Res; 2009 Sep; 69(18):7198-206. PubMed ID: 19738060
[TBL] [Abstract][Full Text] [Related]
8. Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.
Shagisultanova E; Gaponova AV; Gabbasov R; Nicolas E; Golemis EA
Gene; 2015 Aug; 567(1):1-11. PubMed ID: 25967390
[TBL] [Abstract][Full Text] [Related]
9. CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer.
Stanland LJ; Ang HX; Hoj JP; Chu Y; Tan P; Wood KC; Luftig MA
Mol Cancer Res; 2023 Nov; 21(11):1148-1162. PubMed ID: 37493631
[TBL] [Abstract][Full Text] [Related]
10. NEDD9 links anaplastic thyroid cancer stemness to chromosomal instability through integrated centrosome asymmetry and DNA sensing regulation.
Yu HG; Bijian K; da Silva SD; Su J; Morand G; Spatz A; Alaoui-Jamali MA
Oncogene; 2022 May; 41(21):2984-2999. PubMed ID: 35449243
[TBL] [Abstract][Full Text] [Related]
11. Silencing NEDD9 by lentivirus-delivered shRNA inhibits the growth of BxPC-3 cells
Wu T; Dai Y; Xue L; Sheng Y; Zhong Y; Xue Y
Transl Cancer Res; 2019 Sep; 8(5):1873-1881. PubMed ID: 35116938
[TBL] [Abstract][Full Text] [Related]
12. NEDD9 overexpression: Prognostic and guidance value in acute myeloid leukaemia.
Hua S; Feng T; Yin L; Wang Q; Shao X
J Cell Mol Med; 2021 Oct; 25(19):9331-9339. PubMed ID: 34432355
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility-Associated Genetic Variation in
Han D; Owiredu JN; Healy BM; Li M; Labaf M; Steinfeld JS; Patalano S; Gao S; Liu M; Macoska JA; Zarringhalam K; Siegfried KR; Yuan X; Rebbeck TR; Cai C
Cancer Res; 2021 Jul; 81(14):3766-3776. PubMed ID: 33632899
[TBL] [Abstract][Full Text] [Related]
14. Expression of NEDD9 and connexin-43 in neoplastic and stromal cells of gastric adenocarcinoma.
Lerotić I; Vuković P; Hrabar D; Misir Z; Kruljac I; Pavić T; Forgač J; Ćaćić P; Ulamec M
Bosn J Basic Med Sci; 2021 Oct; 21(5):542-548. PubMed ID: 33485292
[TBL] [Abstract][Full Text] [Related]
15. Melatonin Inhibits the Progression of Oral Squamous Cell Carcinoma
Wang Y; Tao B; Li J; Mao X; He W; Chen Q
Front Oncol; 2020; 10():543591. PubMed ID: 33344223
[TBL] [Abstract][Full Text] [Related]
16. Radix Scutellariae Ameliorates Stress-Induced Depressive-Like Behaviors via Protecting Neurons through the TGF
Zhao F; Zhang C; Xiao D; Zhang W; Zhou L; Gu S; Qu R
Neural Plast; 2020; 2020():8886715. PubMed ID: 33273910
[TBL] [Abstract][Full Text] [Related]
17. NEDD9 expression is correlated with epithelial-to-mesenchymal transition markers in colorectal cancer.
Xue YZ; Wu TL; Dai YY; Sheng YY; Wu YM; Xia BL; Huang ZW
Int J Clin Exp Pathol; 2017; 10(8):8640-8646. PubMed ID: 31966721
[TBL] [Abstract][Full Text] [Related]
18. SOX2 promotes hypoxia-induced breast cancer cell migration by inducing NEDD9 expression and subsequent activation of Rac1/HIF-1α signaling.
Wang Y; Bibi M; Min P; Deng W; Zhang Y; Du J
Cell Mol Biol Lett; 2019; 24():55. PubMed ID: 31462898
[TBL] [Abstract][Full Text] [Related]
19. SPAG9 regulates HEF1 expression and drives EMT in bladder transitional cell carcinoma via rac1 signaling pathway.
Li X; Jiang F; Wang X; Gu X
Am J Cancer Res; 2018; 8(12):2467-2480. PubMed ID: 30662804
[TBL] [Abstract][Full Text] [Related]
20. Expression of Nedd9 in Transbronchial Biopsies of Lung Adenocarcinoma.
Ostojić J; Brčić L; Hrabač P; Seiwerth S
Acta Clin Croat; 2018 Jun; 57(2):251-256. PubMed ID: 30431717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
